drugset / Trial / NCT00602225

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00602225

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as clofarabine and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or stopping them from dividing. Colony stimulating factors, such as G-CSF, may increase the number of immune cells found in bone marrow or peripheral blood and may help the immune system recover from the side effects of chemotherapy. PURPOSE: This phase I trial is studying the side effects and best dose of clofarabine to see how well it works when given together with cytarabine and G-CSF in treating patients with relapsed or refractory acute myeloid leukemia

Timeline

Start
2007-12
Primary completion
2010-03
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Clofarabine Other / unclassified Intravenous
Subject Cytarabine Small molecule Intravenous
Background filgrastim Protein / enzyme biologic Subcutaneous